Construction and analysis of the lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional genes in heart failure

Wang,Guohong; Zheng,Xianghui; Zheng,Yang; Cao,Rui; Zhang,Maomao; Sun,Yong; Wu,Jian

doi:10.3892/mmr.2018.9734

Construction and analysis of the lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional genes in heart failure

Authors:
- Guohong Wang
- Xianghui Zheng
- Yang Zheng
- Rui Cao
- Maomao Zhang
- Yong Sun
- Jian Wu
View Affiliations

Affiliations: Department of Cardiovascular Center of Beijing Tongren Hospital, Affiliated to Capital Medical University, Beijing 100730, P.R. China, Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150010, P.R. China, Cardiovascular Department, The First Hospital of Harbin, Harbin, Heilongjiang 150010, P.R. China
Published online on: December 10, 2018 https://doi.org/10.3892/mmr.2018.9734
Pages: 994-1003
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Heart failure (HF) is a principal cause of morbidity and mortality worldwide, affecting an estimated 38 million people. Although significant progress has been made with respect to the underlying molecular mechanisms, the role of the competing endogenous RNA (ceRNA) network in the pathogenesis of HF remains largely unknown. In this study, an HF‑associated ceRNA network was constructed based on the differentially expressed long noncoding RNAs (lncRNAs), microRNAs (miRNAs) and mRNAs obtained, respectively, from the GSE77399, GSE104150 and GSE84796 datasets. The ceRNA network consisted of 12 lncRNA nodes, 43 miRNA nodes, 343 mRNA nodes and 530 edges. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that the ceRNA network was primarily enriched in the immune response, inflammatory response and T cell and B cell receptor signaling pathways. In addition, three lncRNAs (growth arrest specific 5, taurine upregulated 1 and HOX transcript antisense RNA) and three miRNAs [hsa‑miRNA (miR)‑26b‑5p, hsa‑miR‑8485 and hsa‑miR‑940] with higher node degrees compared with other genes were selected as hub nodes. The expression of hub nodes in patients with HF was verified by reverse transcription‑quantitative polymerase chain reaction analysis. The present study provided further insights into the important roles of the ceRNA network in HF development, and indicated the potential use of these hub nodes as diagnostic biomarkers and therapeutic targets.

View Figures

View References

1	Braunwald E: The war against heart failure: The Lancet lecture. Lancet. 385:812–824. 2015. View Article : Google Scholar : PubMed/NCBI
2	Tham YK, Bernardo BC, Ooi JY, Weeks KL and McMullen JR: Pathophysiology of cardiac hypertrophy and heart failure: Signaling pathways and novel therapeutic targets. Arch Toxicol. 89:1401–1438. 2015. View Article : Google Scholar : PubMed/NCBI
3	Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, Murray CJ and Naghavi M: The global burden of ischemic heart disease in 1990 and 2010: The Global burden of disease 2010 study. Circulation. 129:1493–1501. 2014. View Article : Google Scholar : PubMed/NCBI
4	Tanai E and Frantz S: Pathophysiology of heart failure. Compr Physiol. 6:187–214. 2015. View Article : Google Scholar : PubMed/NCBI
5	Kovács Á, Papp Z and Nagy L: Causes and pathophysiology of heart failure with preserved ejection fraction. Heart Fail Clin. 10:389–398. 2014. View Article : Google Scholar : PubMed/NCBI
6	Zhang Y, Bauersachs J and Langer HF: Immune mechanisms in heart failure. Eur J Heart Fail. 19:1379–1389. 2017. View Article : Google Scholar : PubMed/NCBI
7	Hulot JS, Ishikawa K and Hajjar RJ: Gene therapy for the treatment of heart failure: Promise postponed. Eur Heart J. 37:1651–1658. 2016. View Article : Google Scholar : PubMed/NCBI
8	Xu S, Kamato D, Little PJ, Nakagawa S, Pelisek J and Jin ZG: Targeting epigenetics and non-coding RNAs in atherosclerosis: From mechanisms to therapeutics. Pharmacol Ther. Nov 12–2018.(Epub ahead of print). View Article : Google Scholar
9	Wong CM, Tsang FH and Ng IO: Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 15:137–151. 2018. View Article : Google Scholar : PubMed/NCBI
10	Sallam T, Sandhu J and Tontonoz P: Long noncoding RNA discovery in cardiovascular disease: Decoding form to function. Circ Res. 122:155–166. 2018. View Article : Google Scholar : PubMed/NCBI
11	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
12	Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P, Chen Q, Wei C, Fu H, Xu T, et al: Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer. Clin Cancer Res. 24:2002–2014. 2018. View Article : Google Scholar : PubMed/NCBI
13	Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al: NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res. 41:(Database Issue). D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
14	Zheng Y, Zheng X, Li S, Zhang H, Liu M, Yang Q, Zhang M, Sun Y, Wu J and Yu B: Identification of key genes and pathways in regulating immune-induced diseases of dendritic cells by bioinformatic analysis. Mol Med Rep. 17:7585–7594. 2018.PubMed/NCBI
15	Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P, Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2: Indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 44(D1): D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
16	Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, et al: miRTarBase update 2018: A resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 46(D1): D296–D302. 2018. View Article : Google Scholar : PubMed/NCBI
17	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
18	Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, et al: 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol. 70:776–803. 2017. View Article : Google Scholar : PubMed/NCBI
19	Zhang M, Liu F, Jia H, Zhang Q, Yin L, Liu W, Li H, Yu B and Wu J: Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1. J Immunol. 187:1674–1683. 2011. View Article : Google Scholar : PubMed/NCBI
20	Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP and Vidal M: Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 430:88–93. 2004. View Article : Google Scholar : PubMed/NCBI
21	Gao L, Liu Y, Guo S, Yao R, Wu L, Xiao L, Wang Z, Liu Y and Zhang Y: Circulating long noncoding RNA HOTAIR is an essential mediator of acute myocardial infarction. Cell Physiol Biochem. 44:1497–1508. 2017.PubMed/NCBI
22	Greco S, Zaccagnini G, Fuschi P, Voellenkle C, Carrara M, Sadeghi I, Bearzi C, Maimone B, Castelvecchio S, Stellos K, et al: Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure. Cardiovasc Res. 113:453–463. 2017. View Article : Google Scholar : PubMed/NCBI
23	O'Connor CM, Psotka MA, Fiuzat M, Lindenfeld J, Abraham WT, Bristow MR, Canos D, Harrington RA, Hillebrenner M, Jessup M, et al: Improving heart failure therapeutics development in the United States: The heart failure collaboratory. J Am Coll Cardiol. 71:443–453. 2018. View Article : Google Scholar : PubMed/NCBI
24	Pearson MJ, Mungovan SF and Smart NA: Effect of aerobic and resistance training on inflammatory markers in heart failure patients: Systematic review and meta-analysis. Heart Fail Rev. 23:209–223. 2018. View Article : Google Scholar : PubMed/NCBI
25	Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
26	Ulitsky I and Bartel DP: lincRNAs: Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013. View Article : Google Scholar : PubMed/NCBI
27	Shuwen H, Qing Z, Yan Z and Xi Y: Competitive endogenous RNA in colorectal cancer: A systematic review. Gene. 645:157–162. 2018. View Article : Google Scholar : PubMed/NCBI
28	Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D, Wang T and Li X: Competing endogenous RNA networks in human cancer: Hypothesis, validation, and perspectives. Oncotarget. 7:13479–13490. 2016.PubMed/NCBI
29	Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
30	Jiang H, Ma R, Zou S, Wang Y, Li Z and Li W: Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritis. Mol Biosyst. 13:1182–1192. 2017. View Article : Google Scholar : PubMed/NCBI
31	Pang L, Hu J, Zhang G, Li X, Zhang X, Yu F, Lan Y, Xu J, Pang B, Han D, et al: Dysregulated long intergenic non-coding RNA modules contribute to heart failure. Oncotarget. 7:59676–59690. 2016. View Article : Google Scholar : PubMed/NCBI
32	Dick SA and Epelman S: Chronic heart failure and inflammation: What do we really know? Circ Res. 119:159–176. 2016. View Article : Google Scholar : PubMed/NCBI
33	Fildes JE, Shaw SM, Yonan N and Williams SG: The immune system and chronic heart failure: Is the heart in control? J Am Coll Cardiol. 53:1013–1020. 2009. View Article : Google Scholar : PubMed/NCBI
34	Browne AL, Charmsaz S, Varešlija D, Fagan A, Cosgrove N, Cocchiglia S, Purcell S, Ward E, Bane F, Hudson L, et al: Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer. Oncogene. 37:2008–2021. 2018. View Article : Google Scholar : PubMed/NCBI
35	Ovchinnikova ES, Schmitter D, Vegter EL, Ter Maaten JM, Valente MA, Liu LC, van der Harst P, Pinto YM, de Boer RA, Meyer S, et al: Signature of circulating microRNAs in patients with acute heart failure. Eur J Heart Fail. 18:414–423. 2016. View Article : Google Scholar : PubMed/NCBI
36	Vegter EL, Ovchinnikova ES, Silljé HHW, Meems LMG, van der Pol A, van der Velde AR, Berezikov E, Voors AA, de Boer RA and van der Meer P: Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure. PLoS One. 12:e01772422017. View Article : Google Scholar : PubMed/NCBI
37	Liang D, Xu X, Deng F, Feng J, Zhang H, Liu Y, Zhang Y, Pan L, Liu Y, Zhang D, et al: miRNA-940 reduction contributes to human tetralogy of fallot development. J Cell Mol Med. 18:1830–1839. 2014. View Article : Google Scholar : PubMed/NCBI
38	Xu T, Zhou Q, Che L, Das S, Wang L, Jiang J, Li G, Xu J, Yao J, Wang H, et al: Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients. Oncotarget. 7:12414–12425. 2016.PubMed/NCBI
39	Nevers T, Salvador AM, Velazquez F, Ngwenyama N, Carrillo-Salinas FJ, Aronovitz M, Blanton RM and Alcaide P: Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J Exp Med. 214:3311–3329. 2017. View Article : Google Scholar : PubMed/NCBI
40	Tao H, Zhang JG, Qin RH, Dai C, Shi P, Yang JJ, Deng ZY and Shi KH: LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology. 386:11–18. 2017. View Article : Google Scholar : PubMed/NCBI
41	Greco S, Zaccagnini G, Perfetti A, Fuschi P, Valaperta R, Voellenkle C, Castelvecchio S, Gaetano C, Finato N, Beltrami AP, et al: Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med. 14:1832016. View Article : Google Scholar : PubMed/NCBI
42	Lai Y, He S, Ma L, Lin H, Ren B, Ma J, Zhu X and Zhuang S: HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy. Mol Cell Biochem. 432:179–187. 2017. View Article : Google Scholar : PubMed/NCBI
43	Wu Z, Zhao S, Li C and Liu C: LncRNA TUG1 serves an important role in hypoxia-induced myocardial cell injury by regulating the miR-145-5p-Binp3 axis. Mol Med Rep. 17:2422–2430. 2018.PubMed/NCBI